The Economic Times  Apr 17  Comment 
Part of Reed Elsevier group, LexisNexis Legal & Professional serves customers in more than 175 countries with 10,000 employees worldwide.
Reuters  Sep 10  Comment 
* Is or may be case that anticipated acquisition by Reed Elsevier (Uk) Ltd of Jordans Publishing Ltd could result in decrease of competition
TechCrunch  Jul 8  Comment 
 The Berlin- and New York-based language learning service Babbel today announced that it has raised a $22 million funding round led by Scottish Equity Partners. Other participants in this round include previous investors Reed Elsevier Ventures,...
newratings.com  Jun 30  Comment 
LONDON (dpa-AFX) - RELX Group (REL.L, RUK, ENL ) Tuesday said it would complete the simplification of its corporate structure and name changes announced in February, and approved at the Annual General Meetings of the parent companies in...
Benzinga  Jun 10  Comment 
Below are the top publishing-periodicals stocks on the NYSE and the NASDAQ in terms of dividend yield. Value Line, Inc. (NASDAQ: VALU) has a dividend yield of 4.40 percent. Value Line's shares closed at $13.41 on Tuesday. Reed Elsevier NV...
Benzinga  May 19  Comment 
Goldman Sachs upgraded Reed Elsevier plc (ADR) (NYSE: RUK) from Neutral to Buy. Reed Elsevier shares have gained 12.91 percent over the past 52 weeks, while the S&P 500 index has surged 12.95 percent in the same period. Reed Elsevier shares...
Forbes  Apr 27  Comment 
“As head of strategy for a public company I work on a very diverse set of issues and they can be operational or strategic in nature,” explained Kumsal Bayazit, Chief Strategy Officer of  RELX Group in an extensive interview. The company is...
Benzinga  Mar 2  Comment 
Below are the top publishing-periodicals stocks on the NYSE and the NASDAQ in terms of return on investment. The trailing-twelve-month return on investment at Reed Elsevier PLC (NYSE: RUK) is 54.90%. Reed Elsevier's PEG ratio is 3.51. The...
Financial Times  Feb 26  Comment 
FTSE 100 remains in sight of record high


Reed Elsevier PLC (NYSE: RUK) is a publisher and information provider. The company operates in four segments: Elsevier, comprising scientific, technical and medical publishing; LexisNexis, providing legal, tax, regulatory, risk information and analytics, and business information solutions to professional, business and government customers; Reed Exhibitions, organizing trade exhibitions and conferences; and Reed Business Information, providing information and marketing solutions to business professionals.[1]

Business Growth

In 2010, Reed Elsevier's revenues were flat at £6,055 million.[2] The company's adjusted operating profit was lower by 1% at £1,555 million, with adjusted earnings per share down 5% to 43.4 pence.[2] Overall, the company's spend on product development and sales and marketing was offset by cost reductions.[2]

Revenue from LexisNexis grew during the year, with strong growth in the risk business. However, subscription revenues in the legal business continued to reflect the lower levels of law firm activity and employment.[2]

In the risk solutions business, strong growth in the insurance business was supported by high transactional activity in the U.S. auto and property markets.[2] A continuous pipeline of new data and analytics products also drives growth, ranging from helping insurers better assess underwriting risk to reducing cost and improving the effectiveness of the insurers’ workflow.[2]

Reed Exhibitions saw revenue growth from biennial exhibitions and a moderated decline in annual show revenues. The 2010 shows have had growing attendance at the majority of annual events and exhibitor numbers up 4% in the top 50 annual shows.[2] Shows in China, Russia, the Middle East and Brazil, in particular, grew strongly.

Reed Business Information saw growth in data services and online marketing solutions and moderated declines in advertising markets. The sale and closure of the U.S. controlled circulation magazines and certain other titles were completed, together with the sale of clusters of titles in Europe and Asia.[2]


In 2010 Reed Business Information acquired a majority share in the leading petrochemical and energy information service in China, CBI China.[2] In February 2011, the company acquired Shanghai Datong Medical Information Technology Co., Ltd.[1]

Trends and Forces

Demise of print publications

Reed Elsevier has seen a significant migration from print products to electronic content and tools over the last ten years.[2] In fact, print revenues now account for only 25% of revenues, while electronic content accounts for 61% of revenue. This trend will likely continue, meaning Reed Elsevier will need to continue to transition away from print publications and invest more in electronic formats. This is an industry wide trend reflecting the convenience of accessing information digitally rather than in print format.

Image: Elsevier.gif

New revenue models may adversely impact Reed Elsevier's revenue

Reed Elsevier's scientific, technical and medical (STM) publications are published on a paid subscription basis. There has been an ongoing debate among academics, the government, and libraries regarding whether such publications should be funded instead through fees charged to authors and from governmental and other subsidies or made freely available after a period following publication. If these methods of STM publishing are widely adopted or mandated, it would adversely affect Reed Elsevier's revenue from paid subscription publications.[3]


Reed Elsevier operates in a highly competitive information and publishing industry, competing with heavyweights like McGraw Hill (MHP), Scholastic (SCHL), and Thomson Reuters (TRI). Reed Elsevier continually innovates and adds new research products to its portfolio in order to keep up with competitors.


  1. 1.0 1.1 Reuters: RUK
  2. 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 Reed Elsevier Investor Relations: Chief Executive Officer's Report
  3. Reed Elsevier Annual Report 2010: Principal Risks
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki